Celebrating 25 Years of Excellence

IPO Readiness

Day 1 Highlights | 2023 AICPA & CIMA Conference on Current SEC and PCAOB Developments

SEC Reporting Considerations for Carve-Out Transactions

Navigating the New Disclosure and Policy Requirements in Response to the SEC’s Clawback Rule

2023 Financial Statement Filing Deadlines and Staleness Calendar

Cybersecurity: Not a One Size Fits All

Oculis Announces Public Listing After Completing Business Combination Between European Biotech Acquisition Corp. And Oculis SA

Third Harmonic Bio Closes Upsized Initial Public Offering of Shares of Common Stock Trading on the NASDAQ Global Market

Navigating the Proposed SEC Rules on Accounting for Obligations to Safeguard Crypto-assets

Key Takeaways From the 2022 AICPA & CIMA Conference on Current SEC and PCAOB Developments

Senti Biosciences Completes Merger With Dynamics Special Purpose Corp.